Charles Ned Sannar, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9900 Larkin Rd, Live Oak, CA 95953 Phone: 530-695-1892 |
Dr. Bruce M Pope, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9900 Larkin Rd, Live Oak, CA 95953 Phone: 530-695-1884 Fax: 530-695-1994 |
Dr. Renee Kameko Tanabe, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 9900 Larkin Rd, Live Oak, CA 95953 Phone: 530-695-1884 |
News Archive
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.
While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.
Manufacturing small proteins known as peptides is usually very time-consuming, which has slowed development of new peptide drugs for diseases such as cancer, diabetes, and bacterial infections.
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
› Verified 8 days ago